At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 552 enrolled
Drug / intervention
Typhoid Vi Polysaccharide Vaccine +4 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Adults
In Brief
A Phase 3 clinical trial evaluating Typhoid Vi Polysaccharide Vaccine, Yellow Fever Vaccine, and 3 other interventions for Meningococcal Disease and 5 related conditions. Completed, enrolled 552 participants across 5 sites in 2 countries.
Detailed Summary
This study compares the safety and immunogenicity profile of several travel vaccines given alone or concomitantly with MenACWY-CRM to healthy adults.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMeningococcal Disease, Meningococcal Meningitis, Typhoid, Yellow Fever, Rabies, Japanese Encephalitis
CountriesCzechia, Germany
CollaboratorsNovartis Vaccines
Timeline
Phase 3CompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2011
First PostedNov 2011
Primary CompletionApr 2012
TodayJul 2026
First PostedNov 8, 2011
Enrollment StartNov 1, 2011
Primary CompletionApr 1, 2012
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 14.7 years ago
Interventions
Typhoid Vi Polysaccharide Vaccinebiological
One dose of typhoid Vi polysaccharide vaccine.
Yellow Fever Vaccinebiological
One dose of yellow fever vaccine.
Japanese Encephalitis Vaccinebiological
Two doses of Japanese Encephalitis Vaccine.
Rabies Vaccinebiological
Three doses of Rabies vaccine.
MenACWY-CRM Vaccinebiological
One dose of MenACWY-CRM vaccine.